Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: Significance of morphometry, hormone receptors and apoptosis for outcome prediction

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 11, 2009, Pages 1234-1242

  Ørbo, Anne ^a   Kaino, Turid ^a   Arnes, Marit ^a   Larsen, Kurt ^a   Pettersen, Inger ^a   Moe, Bjørn ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NONE

Author keywords

Endometrial carcinoma; High risk endometrial hyperplasia

Indexed keywords

CASPASE 3; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HORMONE RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN BAX; PROTEIN BCL 2; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER SURGERY; CLINICAL FEATURE; D SCORE; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHOMETRICS; NORWAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; APOPTOSIS; BIOPSY; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 70449596144     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903281014     Document Type: Article

References (25)

1. Baak JP, Nauta JJ, Wisse-Brekelmans EC, Bezemer PD. Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone. J Pathol. 1988;154:335-341
2. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985;56:403-412
3. Mutter GL. Diagnosis of premalignant endometrial disease. J Clin Pathol. 2002;55:326-331
4. Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E, et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol. 1999;23:1102-1108
5. Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M, et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and welldifferentiated carcinoma. Am J Surg Pathol. 1998;22:1012-1019
6. Baak JP, Mutter GL. EIN and WHO94. J Clin Pathol. 2005;58:1-6.
7. Baak JP, Orbo A, Van Diest PJ, Jiwa M, De BP, Broeckaert M, et al. Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. Am J Surg Pathol. 2001;25:930-935
8. Baak JP, Mutter GL, Robboy S, Van Diest PJ, Uyterlinde AM, Orbo A, et al. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005;103:2304-2312
9. Orbo A, Baak JP, Kleivan I, Lysne S, Prytz PS, Broeckaert MA, et al. Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway. J Clin Pathol. 2000;53:697-703.
10. Orbo A, Arnes M, Hancke C, Vereide AB, Pettersen I, Larsen K. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol. 2008;111:68-73.
11. Baak JP, Kurver PH, Diegenbach PC, Delemarre JF, Brekelmans EC, Nieuwlaat JE. Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy - a feasibility study. Histopathology. 1981;5:61-68
12. Bozdogan O, Atasoy P, Erekul S, Bozdogan N, Bayram M. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium. Int J Gynecol Pathol. 2002;21:375-382
13. Mylonas I, Makovitzky J, Friese K, Jeschke U. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium. Acta Histochem. 2009; 111:349-359
14. Vereide AB, Arnes M, Straume B, Maltau JM, Orbo A. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol Oncol. 2003;91:526-533
15. Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol. 2005;18:324-330
16. Orbo A, Baak JP. Computer-based morphometric image analysis of endometrial hyperplasia. Tidsskr Nor Laegeforen. 2000;120:496-499
17. Mutter GL, Kauderer J, Baak JP, Alberts D. Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study. Hum Pathol. 2008;39:866-874
18. Huang A, Pettigrew NM, Watson PH. Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody. J Pathol. 1996;180:223-227
19. Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:804-811
20. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006; 106:812-819 (Pubitemid 43238448)
21. Pennant S, Manek S, Kehoe S. Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review. J Obstet Gynaecol. 2008;28:632-633
22. Arnett-Mansfield RL, DeFazio A, Wain GV, Jaworski RC, Byth K, Mote PA, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res. 2001;61:4576-4582
23. Hu K, Zhong G, He F. Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma. Int J Gynecol Cancer. 2005;15:537-541
24. Snijders MP, De Goeij AF, Koudstaal J, Thunnissen EB, De Haan J, Bosman FT. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol. 1992;166:171-177
25. Vereide AB, Kaino T, Sager G, Arnes M, Orbo A. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia. Gynecol Oncol. 2006; 101:214-223